LIBRA INFUSIONS LIMITED

Similar documents
JUTE SPINNERS LIMITED Notes to the Financial Statements as at and for the year ended 30 June 2012

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Auditors Report To The Shareholders of BEXIMCO PHARMACEUTICALS LIMITED

Auditors Report To The Shareholders of BEXIMCO PHARMACEUTICALS LIMITED

Monno Ceramic Industries Ltd.

Monno Ceramic Industries Ltd.

PHARMA-DEKO PLC. UNAUDITED 1 ST QUARTER ENDED MARCH 31ST, 2013 FINANCIAL REPORT. Prepared in accordance with IFRS & IAS 34

Jyothy Kallol Bangladesh Limited. Auditor s Report and Financial Statements for the year ended 31 March 2017

Agro Tech Foods (Bangladesh) Pvt. Ltd.

Dutch-Bangla Bank Limited

Responsibility & Main Duties of Chief Executive Officer and Chief Financial Officer on Financial Reporting of the Company

Responsibility & Main Duties of Chief Executive Officer and Chief Financial Officer on Financial Reporting of the Company

Auditor s Report to the shareholders of Prime Bank Securities Limited

ANJUM TEXTILE MILLS (PVT) LTD. BALANCE SHEET AS AT JUNE 30, 2014

ANJUM TEXTILE MILLS (PVT.) LTD. BALANCE SHEET AS AT JUNE 30, 2012

Notes to the Financial Statements for the year ended 31 December 2006

Interim Financial Statements (Un-audited) 1 st Quarter Ended September 30, 2016

AUDITORS' REPORT To the shareholders of

UTTARA BANK LIMITED FINANCIAL STATEMENTS MARCH 2017 (UN-AUDITED)

Chief Executive. March 7, Annual Report 2007 Azgard 9 21

UNIVERSITY PRESS PLC FINANCIAL STATEMENTS 31 MARCH 2015

ANNUAL REPORT

APPAJI & CO. CHARTERED ACCOUNTANTS INDEPENDENT AUDITOR S REPORT. To the members of WIPRO YARDLEY FZE, DUBAI

QATAR GENERAL INSURANCE AND REINSURANCE COMPANY S.A.Q. CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2010

CHELLARAMS PLC RC 639

GAPCO UGANDA LIMITED. Gapco Uganda Limited

GlaxoSmithKline Bangladesh Limited

UTTARA BANK LIMITED FINANCIAL STATEMENTS 31 MARCH 2018 (UN-AUDITED)

RAK INVESTMENT AUTHORITY GOVERNMENT OF RAS AL KHAIMAH AND ITS SUBSIDIARIES

MUGHAL IRON & STEEL INDUSTRIES LIMITED FINANCIAL STATEMENTS. for the year ended June 30, Annual Report for the year ended June 30, 2015 /

WIPRO TECHNOLOGIES NORWAY AS FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED MARCH 31, 2015

Consolidated Financial Statements

Income Statements...39 Statements of Recognised Income and Expense...40 Balance Sheets...41 Statements of Cash Flows...42

Persistent Systems France SAS

Auditors Report & Audited Financial. Statements of. Grameenphone IT Ltd.

Interim Financial Statements (Un-audited) For the Half Year Ended December 31, 2016

Interim Financial Statements (Un-audited) 1 st Quarter Ended September 30, 2017

GAPCO UGANDA LIMITED. GAPCO Uganda Limited

TRANS-NATIONWIDE EXPRESS PLC PERIOD ENDED MARCH 31, 2016 TABLE OF CONTENTS. Statement of Accounting Policies

Qatari German Company for Medical Devices Q.S.C.

WE CREATE OPPORTUNITIES

ORION PHARMA LIMITED AND ITS SUBSIDIARIES

Notes. 332,980 Website net. 7 65,318 Deposit on building 150,000. Total Assets 652,546

MEGA Brands Inc. Consolidated Financial Statements December 31, 2012 and 2011 (in thousands of US dollars)

Middle East Specialized Cables Company (MESC) (A Saudi Joint Stock Company)

UTTARA BANK LIMITED QUARTERLY FINANCIAL STATEMENT MARCH 31,2015 (UN-AUDITED)

Interim Financial Statements (Un-audited) For the Half Year Ended December 31, 2017

QATARI GERMAN COMPANY FOR MEDICAL DEVICES Q.S.C. FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2013

Ranbaxy Pharmaceuticals Canada Inc.

Caspian Drilling Company LLC Consolidated financial statements

Dutch-Bangla Bank Limited Balance Sheet As at 30 September 2017 (Main Operation and Off-shore Banking Unit)

Gulf Warehousing Company (Q.S.C.) CONSOLIDATED FINANCIAL STATEMENTS

QUARTERLY FINANCIAL STATEMENTS (Un-Audited) For the 1st Quarter ended September 30, 2016

Qatar General Insurance and Reinsurance Company S.A.Q. CONSOLIDATED FINANCIAL STATEMENTS

BC LIQUOR DISTRIBUTION BRANCH

DALLAH HEALTH CARE HOLDING COMPANY (A Saudi Joint Stock Company)

Gulf Pharmaceutical Industries P.S.C. Condensed consolidated interim financial information (Unaudited) for the three month period ended 31 March 2017

KALPATARU POWER DMCC

Berger Paints Trinidad Limited

Financial Statements Cimento Tupi S.A. December 31, 2012 with Independent Auditors Report on Financial Statements

Kosovo Railways JSC Hekurudhat e Kosovës Sh.A. Kosovske Železnice D.D. Pristina, Kosovo. Financial statements for the year ended 31 December 2005

Audit Report of Certified Public Accountant

PJSC Enel Russia Consolidated financial statements. For the year ended 31 December 2016 with independent auditor s report

EKO PETROLEUM ALBANIA Shpk. FINANCIAL STATEMENTS 31 DECEMBER 2011

Bangladesh General Insurance Company Ltd. Balance Sheet (Statement of Financial Position) As at December 31, 2017

MIDDLE EAST SPECIALIZED CABLES COMPANY (A Saudi Joint Stock Company)

Annual Report for the year ended June 30, 2014 FINANCIAL STATEMENTS

Auditors Report to the Members

TRANS-NATIONWIDE EXPRESS PLC PERIOD ENDED JUNE 30, 2017 TABLE OF CONTENTS CONTENTS PAGE

Strongco Corporation. Consolidated Financial Statements December 31, 2012

YIOULA GLASSWORKS S.A. AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2012

Vitafoam Nigeria Plc. Consolidated and Separate financial statements Year ended 30 September 2014

Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report

QATAR GENERAL INSURANCE AND REINSURANCE COMPANY S.A.Q. CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2009


Aepona Limited CONDENSED BALANCE SHEET AS AT MARCH 31, 2016

Ambee Pharmaceuticals Limited 1st Quarter Accounts(Un-Audited) July to September-2018

HONEY BUN (1982) LIMITED Financial Statements 30 September 2017

Financial statements and independent auditors report Korporata Energjetike e Kosoves 31 December 2005

BİM Birleşik Mağazalar Anonim Şirketi. Financial Statements March 31, 2008

2

2

CanWel Building Materials Group Ltd.

RELIANCE CLOTHING INDIA PRIVATE LIMITED 1. Reliance Clothing India Private Limited

YIOULA GLASSWORKS S.A. AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2011

CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2013

Financial Statements 2017 of Mercantile Bank Limited

Ambee Pharmaceuticals Limited 3rd Quarter Accounts(Un-Audited) January to March-2018

Fin UNIVANICH. The notes to financial statements form an integral part of these financial statements. TEMENTS

MEGA Brands Inc. Consolidated Financial Statements December 31, 2013 and 2012 (in thousands of US dollars)

Changes in Existing Decommissioning, Restoration and Similar Liabilities

Rahman Rahman Huq Chartered Accountants. 9 & 5 Mohakhali C/A Dhaka-1212, Bangladesh

NOTES TO THE FINANCIAL STATEMENTS

AUDITORS REPORT TO THE SHAREHOLDERS OF Sonali Bank Limited

DALLAH HEALTHCARE HOLDING COMPANY (A Saudi Joint Stock Company)

REPORT OF INDEPENDENT AUDITOR

CONSOLIDATED STATEMENT OF FINANCIAL POSITION as at 31 March 2016

DALLAH HEALTHCARE HOLDING COMPANY (A Saudi Joint Stock Company)

OIL AND GAS DEVELOPMENT COMPANY LIMITED BALANCE SHEET AS AT 30 JUNE 2013

Auditors Report to the Members

Transcription:

LIBRA INFUSIONS LIMITED The Notes are integral part of the Financial Statements As at and for the year ended 30 June 2015 1. Company Profile Libra Pharmaceuticals Limited was incorporated in Bangladesh as a Private Limited Company on 2 February 1976 under the Companies Act, 1913. It was converted into a Public Limited Company in 1994 when it offered its share to the Public with the permission of the Bangladesh Securities and Exchange Commission. Subsequently it was renamed as Libra Infusions Limited on 27 October 1999. The shares of the company are publicly traded on the floors of Dhaka Stock Exchange Limited and Chittagong Stock Exchange Limited. 2. Head office, Factory and Depot Office The Registered Office and Factory are situated at I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka-1216. The Company is being operated through its Depot / Sales offices located at Dhaka, Mymensingh, Comilla, Sylhet, Noakhali, Chittagong, Faridpur, Barisal, Khulna, Bogra, Rangpur, Rajshahi and Kushtia. 3. Nature of Business The company owns and operates modern Injectable Intravenous (I.V) Fluids, Pharmaceutical products and Mineral Water manufacturing factories and it sells life saving products of different quality / grades to Govt, Semi Govt, Authorities Hospitals, Clinics and Licenses Pharmacies. 4. Basis of Measurement of Elements of Financial Statements The financial statements have been prepared on the Historical Cost Basis except land and buildings revalued by the Valuer following current cost method. 5. Statement on Compliance with Local Laws The financial statements have been prepared in compliance with the requirements of the Companies Act, 1994, the Bangladesh Securities & Exchange Rules1987, the Listing Regulations of Dhaka and Chittagong Stock Exchanges and other relevant local laws as applicable. 1

6. Statement on Compliance of Bangladesh Accounting Standards The financial statements have been prepared in accordance with the applicable Bangladesh Accounting Standard (BASs) adopted by the Institute of Chartered Accountants of Bangladesh (ICAB) based on International Accounting Standards (IASs) and International Financial Reporting Standards (IFRSs). 7. Compliance of International/Bangladesh Accounting Standards - (IAS/BAS) The accounting standards that underpin the policies adopted by the company can be found in the following places of the notes to the financial statements: BAS/BFRS DESCRIPTION NOTE REFERENCE BAS 1 : Presentation of Financial Statements 8, 9,29 BAS 2 : Inventories 18 BAS 7 : Cash Flow Statements 28 BAS 8 : Accounting Policies, Changes in Accounting 17 Estimates and Errors BAS 10 : Events after the Balance Sheet Date 31 BAS 12 : Income Taxes 12.2.5 BAS 14 : Segment Reporting 27 BAS 16 : Property, Plant and Equipment 12.2.3 BAS 18 : Revenue 12.1 BAS 19 : Employee Benefits 12.2.8 BAS 21 : The effects of Changes in Foreign Exchange 13 Rates BAS 24 : Related Party Disclosures 30 BAS 27 : Consolidated Financial Statements and 56 Accounting for Investment in Subsidiary BAS 33 : Earnings Per Share 12.2.10 2

8. Presentation of Financial Statements According to the International Accounting Standard (IAS) -1 as adopted by ICAB as BAS 1 Presentation of Financial Statements the complete set of Financial Statements includes the following components - (a) Statement of Financial Position as at 30 June 2015; (b) Statement of Comprehensive Income for the year ended 30 June 2015; (c) Statement of Changes in Equity for the year ended 30 June 2015; (d) Statement of Cash Flows for the year ended 30 June 2015; and (e) Notes to the Financial Statements as at and for the year ended 30 June 2015. 9. Structure, Content and Presentation of Financial Statements Being the general purpose of financial statements, the presentation of these financial statements is in accordance with the guidelines provided by BAS 1: Presentation of Financial Statements. 10. Reporting Period The financial period of the company covers one financial year from 1 July 2014 to 30 June 2015. 11. Accounting Principles and Policies The accounting principles and policies in respect of material items of financial statements set out below have been applied consistently to all periods presented in these financial statements. 12. Use of Estimates and Judgments The preparation of Financial statements in conformity with IFRSs including IASs require management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses that require disclosure, during and at the date of the financial statements. 12.1 Revenue Recognition Policy In compliance with the requirements of BAS- 18: Revenue, revenue receipts from customers against sales is recognized when products are dispatched to customers, that is, when the significant risk and rewards of ownership have been transferred to the buyer, recovery of the consideration is probable, the associated costs and possible return of goods can be estimated reliably and there is no continuing management involvement with the goods. 3

Revenue from sales is exclusive of VAT. 12.2 Property, Plant and Equipment 12.2.1 Recognition and Measurement This has been stated at cost or revalued amount less accumulated depreciation in compliance with the requirements of IAS 16: Property, Plant and Equipment. The cost of acquisition of an asset comprises its purchase price and any directly attributable cost of bringing the assets to its working condition for its intended use inclusive of inward freight, duties and non-refundable taxes. 12.2.2 Maintenance Activities The company incurs maintenance costs for all its major items of property, plant and equipment. Repair and maintenance costs are charged as expenses when incurred. 12.2.3 Depreciation on Fixed Assets Depreciation is provided to amortize the cost of the assets after commissioning, over the period of their expected useful lives, in accordance with the provisions of BAS -16: Property, Plant and Equipment. Depreciation is provided for the period in use of the assets. Depreciation is provided at the following rates on reducing balance basis: Building and Other Construction 1.25% Plant, Machinery and Equipment 5% Furniture and Fixtures 6% Vehicles 10% - 20% Books & Journal 30% Depreciation on addition to Fixed Assets of Unit 1 has been charged for six months averagely and No depreciation has been provided on Unit-2 on during the year 2014-2015. 12.2.4 Cash and Cash Equivalents Cash and cash equivalents include cash in hand, in transit and with banks on current and deposit accounts which are held and available for use by the company without any restriction. There is insignificant risk of change in value of the same. 12.2.5 Income Tax Income tax comprise of current and deferred tax. Income tax is recognized in statement of comprehensive income and accounted for in accordance with the requirements of BAS 12: Income Tax. 4

12.2.6 Current Tax Current tax is the expected tax payable for the year, and any adjustment to tax in respect of previous years. The company qualifies as a Publicly Traded Company hence the applicable Tax Rate is 25.00%. 12.2.7 Deferred Tax Deferred tax has been considered and reflected in the accounts under review. The impact of changes on the account in the deferred tax assets and liabilities has also been recognized in the profit and loss account as per BAS-12 Income Taxes. 12.2.8 Employee Benefits a) Provident Fund: The company has established a contributory provident fund scheme. The fund is wholly administered by a Board of Trustees. No part of the fund is included in the assets of the company. b) Workers Profit Participation Fund and Welfare Fund: The company makes a regular allocation of 5% on net profit before tax to this fund and payment is made to the workers and staffs as per provision of the companies Profit under Labour Act 2006. 12.2.9 Proposed Dividend Proposed dividend is accounted for after approval by the shareholders in the Annual General Meeting. 12.2.10 Earning Per Share (EPS) Earning per Share (EPS) is calculated in accordance with Bangladesh Accounting Standard BAS - 33 Earning Per Share by dividing the basic earnings by weighted average number of ordinary shares outstanding during the year. Basic Earning per share Earning per share has been calculated by dividing the earnings attributable to the number of ordinary shares held by the members during the year. Diluted Earnings per Share No diluted EPS was required to be calculated for the year under review as there is no scope for dilution of EPS for the year. 5

13. Foreign Currency Transactions Foreign currency transactions are recorded at the applicable rates of exchange ruling at the transaction date. The monetary, assets and liabilities, if any, denominated in foreign currencies at the balance sheet date are translated at the applicable rates of exchanges ruling at that date. Exchange differences are charged off as revenue expenditure in compliance with the provision of BAS 21: The Effects of Changes in Foreign Exchange Rates. 14. Approval of Financial statements The financial statements were approved by the Board of Directors on 27 October 2015. 15. Reporting Currency The financial statements are prepared and presented in Bangladesh Currency (Taka), which is the company s functional currency. All financial information presented has been rounded off to the nearest Taka except where indicated otherwise. 16. Comparative Information and Rearrangement Thereof Comparative information has been disclosed in respect of the financial year 2013 2014 for all numerical information in the financial statements and also the narrative and descriptive information where it is relevant for understanding of the current year s financial statements. Head of accounts and figures for the financial year 2013 2014 including narrative and descriptive information have been re-arranged and regrouped wherever considered necessary to ensure better comparability with the current year. 17. Risk and Uncertainty for use of Estimates and Judgments The preparation of financial statements in conformity with Bangladesh Accounting Standards requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses and for contingent assets and liabilities that require disclosure, during and at the date of the financial statements. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Any revision of accounting estimates are recognized in the period in which the estimate is revised and in any future periods affected as required by BAS 8: Net Income or Loss for the Period Fundamental Errors and Changes in Accounting Policies. 6

18. Inventories Inventories are stated at the lower of cost or net realizable value in compliance with the requirements of Para 21& 25 of BAS-2. The cost is calculated on weighted average method in a consistent manner. Costs comprise of expenditure incurred in the normal course of business in bringing out such inventories to its location and conditions. Where necessary, provision is made for obsolete, slow moving and defective inventories if any) identified at the time if physical verification of inventories. Cost of work in progress is determined at the basis of cost of materials only. 19. Board of Directors & Board Meetings There are 08 Members in the Board of Directors of the Company, 10 Board meetings were held during the year to transact various business. 20. Audit Fee As per decision taken in the 36 th Annual General Meeting of the Company held on 28 December 2014 the audit fee of TK. 80,000 has been provided for in the accounts. During the year under audit nothing was paid to the auditors for any other services. 21. Accrued Expenses and Other Payables Liabilities for the goods and services received have been accounted for. Payables are not interest bearing and are stated at their nominal value. 22. Going Concern The company has adequate resources to continue in operation for the foreseeable future. For this reason the directors continue to adopt going concern basis in preparing the financial statements. 23. Financial Instrument Non-derivative financial instruments comprise accounts and other receivables, cash and cash equivalents, borrowings and other payables and are shown at transaction cost. 7

24. Impairment In accordance with the provisions of BAS 36: Impairment of Assets, the carrying amount of non-financial assets, other than inventories is reviewed at each reporting date to determine whether there is any indication of impairment. If any such indication exists, then the asset s recoverable amount is estimated and impairment losses are recognized if profit and loss account. No such indication of impairment has been raised till to date. 25. Accounts Receivable Accounts receivable are created at original invoice amount less any provisions are made where there is evidence of a risk of non-payment, taking into account aging, previous experience and general economic conditions. When an accounts receivable is determined to be uncollectible it is written off, firstly against any provision available and then to statement of comprehensive income. Subsequent recoveries of amounts previously provided for are credited to the statement of comprehensive income account. 26. Provisions A provision is recognized on the statement of financial position date if, as a result of post events, the company has a present legal or constructive obligation that can be estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation. 27. Segment Reporting No segment reporting is applicable for the company as required by BAS-14: Segment reporting, as the company operates in a single industry segment. 28. Statement of Cash Flow The Statement of Cash Flow has been prepared in accordance with the requirements of BAS- 7: Cash Flow Statements. The cash generating from operating activities has been reported using the Direct Method as prescribed by the Securities and Exchange Rules, 1987 and as the benchmark treatment of BAS-7 whereby major classes of gross cash receipts and gross cash payments from operating activities are disclosed. 8

29. Proposed Dividend The amount of proposed dividend has not accounted for but disclosed in the notes to the accounts along with the dividend per share in accordance with the requirements of Para 125 of BAS- 1: Presentation of Financial Statements. Also, the proposed dividend has not been considered as Liability in accordance with the requirements of the Para 12 & 13. 30. Transactions with Related Parties There were no transactions with related parties in the normal course of business and on arm s length basis. The information as required by BAS 24. 31. Events after Reporting Period Events after the reporting period that provide additional information about the company s position at the date of Statement of Financial Position or those that indicate that the going concern assumption is not appropriate are reflected in the Financial Statements. Events after reporting period that are not adjusting events are disclosed in the notes when material. 9